Multiple system atrophy (MSA)

Causes and pathology

MSA is characterized by progressive loss of neurons and supportive cells in multiple brain areas. Pathological studies reveal degeneration of neurons and abnormal protein inclusions in oligodendrocytes, most notably aggregates of alpha-synuclein. Affected brain structures include the basal ganglia, brainstem nuclei, and cerebellar pathways. These widespread changes explain the diversity of clinical features.

Clinical features

MSA typically presents in adulthood with a variable mix of problems. Common manifestations include:

• Autonomic failure: orthostatic hypotension, urinary incontinence or retention, erectile dysfunction, and impaired sweating.
• Parkinsonism: slowness of movement, rigidity, postural instability and sometimes tremors, often with a poor or transient response to dopaminergic drugs.
• Cerebellar signs: gait and limb incoordination described as ataxia, dysarthria, and balance difficulties.

Diagnosis, subtypes and course

Diagnosis is clinical and based on the pattern of symptoms, supported by imaging and autonomic testing. MSA is commonly classified into predominant parkinsonian (MSA-P) and predominant cerebellar (MSA-C) subtypes. Magnetic resonance imaging can show characteristic changes in some patients, and progressive dysfunction usually leads to increasing disability. MSA shares similarities with Parkinson's disease and other movement disorders, which can complicate early diagnosis.

History and nomenclature

The condition was historically described under several names (for example Shy–Drager syndrome, striatonigral degeneration, olivopontocerebellar atrophy) before the unifying term multiple system atrophy became common. This reflects recognition that a single disease process can affect multiple motor and autonomic systems.

Management and outlook

There is no cure. Care focuses on symptom control: managing blood pressure and bladder problems, physiotherapy for mobility, speech therapy, and judicious use of medications for parkinsonism. Prognosis is variable but generally progressive; multidisciplinary care aims to maintain quality of life. Reliable specialist information and clinical guidance are available from professional and patient resources (cerebellar resources, support groups, disease overviews, research summaries, pathology reports, symptom guides, anatomy references, comparative reviews).